Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2020 08:40 ET | Source: Anpac Bio, USA

AnPac Bio Completed 1st Half Year with Increased ASP and Revenue

SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
July 08, 2020 20:32 ET | Source: General Atomics

Diazyme Laboratories, Inc. Receives FDA EUA for COVID-19 Antibody Test

SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgG CLIA test. The Diazyme IgG test is run on...
June 30, 2020 19:15 ET | Source: ReportLinker

Global Cholesterol Testing Market By Indication, By Product, By End-Product, By Test, By Age, By End-User, By Region, Forecast & Opportunities, 2025

New York, June 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cholesterol Testing Market By Indication, By Product, By End-Product, By Test, By Age, By...
June 26, 2020 08:00 ET | Source: Anpac Bio, USA

AnPac Bio Ranked #3 in Liquid Biopsy Clinical Samples Globally by Frost & Sullivan While Retaining #1 Position and Widening its Lead in China in Cancer Screening

SAN JOSE, Calif., June 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
June 22, 2020 08:46 ET | Source: Anpac Bio, USA

AnPac Bio Launches New Immunology Test Product Line

SAN JOSE, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
June 19, 2020 08:00 ET | Source: Anpac Bio, USA

AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening

SAN JOSE, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
June 16, 2020 01:36 ET | Source: Allied Market Research

AMR：2026年亚太肿瘤分子诊断市场将达7.305亿美元

Portland, OR, June 16, 2020 (GLOBE NEWSWIRE) -- 根据联合市场研究公司（Allied Market Research）发布的报告，亚太肿瘤分子诊断市场在2018年产生了3.484亿美元，到2026年估计将达到7.305亿美元，从2019年到2026年的复合年增长率为9.0％。该报告提供了广泛的分析...
June 16, 2020 01:36 ET | Source: Allied Market Research

2026 년까지 $ 732.05Million에 도달하는 아시아 태평양 종양학 분자 진단 시장 : AMR

Portland, OR, June 16, 2020 (GLOBE NEWSWIRE) -- Allied Market Research에서 발표 한 보고서에 따르면아시아 태평양 종양학 분자 진단 시장이 보고서는 2018 년에 383 억 8,800 만 달러를 창출했으며 2026 년까지 2019 년에서 2026 년까지 연평균 9.0 %의 CAGR을 기록한 3 억...
June 16, 2020 01:36 ET | Source: Allied Market Research

Asia-Pacific Oncology Molecular Diagnostics Market to Reach $732.05Million by 2026: AMR

Portland, OR, June 16, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research,the Asia-Pacific oncology molecular diagnostics market generated $381.84 million in 2018,...
June 12, 2020 09:53 ET | Source: Allied Market Research

Covid-19診断市場が2020年末までに4億4,540万ドルを生み出す：AMR

Portland, OR, June 12, 2020 (GLOBE NEWSWIRE) -- Allied Market Researchのレポートによると、グローバルなcovid-19診断市場は2020年の第1四半期に710万ドルを獲得し、2020年の第4四半期までに4億4540万ドルを生み出すと推定されています。主要な勝利戦略、投資ポケット、主要セグメント、競争環境。 ...